Hypera SA
Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, Luna, moon, Lydian, macrodantin, MaxSulid, Milgamm… Read more
Hypera SA (HYPMY) - Total Assets
Latest total assets as of September 2025: $28.53 Billion USD
Based on the latest financial reports, Hypera SA (HYPMY) holds total assets worth $28.53 Billion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Hypera SA - Total Assets Trend (2005–2024)
This chart illustrates how Hypera SA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Hypera SA - Asset Composition Analysis
Current Asset Composition (December 2024)
Hypera SA's total assets of $28.53 Billion consist of 27.2% current assets and 72.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 7.1% |
| Accounts Receivable | $2.25 Billion | 9.2% |
| Inventory | $1.94 Billion | 7.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $4.45 Billion | 18.1% |
| Goodwill | $7.34 Billion | 29.9% |
Asset Composition Trend (2005–2024)
This chart illustrates how Hypera SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hypera SA's current assets represent 27.2% of total assets in 2024, a decrease from 45.9% in 2005.
- Cash Position: Cash and equivalents constituted 7.1% of total assets in 2024, up from 0.2% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 47.0% of total assets, an increase from 37.0% in 2005.
- Asset Diversification: The largest asset category is goodwill at 29.9% of total assets.
Hypera SA Competitors by Total Assets
Key competitors of Hypera SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Hypera SA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Hypera SA generates 0.30x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Hypera SA generates $5.46 in net profit.
Hypera SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.27 | 1.81 | 3.01 |
| Quick Ratio | 0.84 | 1.41 | 2.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.33 Billion | $ 3.94 Billion | $ 5.27 Billion |
Hypera SA - Advanced Valuation Insights
This section examines the relationship between Hypera SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.13 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 0.2% |
| Total Assets | $24.56 Billion |
| Market Capitalization | $1.06 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Hypera SA's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Hypera SA's assets grew by 0.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Hypera SA (2005–2024)
The table below shows the annual total assets of Hypera SA from 2005 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $24.56 Billion | +0.21% |
| 2023-12-31 | $24.51 Billion | +3.17% |
| 2022-12-31 | $23.76 Billion | +19.87% |
| 2021-12-31 | $19.82 Billion | +14.89% |
| 2020-12-31 | $17.25 Billion | +44.72% |
| 2019-12-31 | $11.92 Billion | +12.91% |
| 2018-12-31 | $10.56 Billion | +4.21% |
| 2017-12-31 | $10.13 Billion | -11.80% |
| 2016-12-31 | $11.49 Billion | -27.42% |
| 2015-12-31 | $15.82 Billion | +13.94% |
| 2014-12-31 | $13.89 Billion | +11.08% |
| 2013-12-31 | $12.50 Billion | -1.22% |
| 2012-12-31 | $12.66 Billion | -5.02% |
| 2011-12-31 | $13.33 Billion | +33.42% |
| 2010-12-31 | $9.99 Billion | +58.84% |
| 2009-12-31 | $6.29 Billion | +76.35% |
| 2008-12-31 | $3.57 Billion | +80.93% |
| 2007-12-31 | $1.97 Billion | +517.30% |
| 2006-12-31 | $319.23 Million | +23.92% |
| 2005-12-31 | $257.60 Million | -- |